Active Roster
Media
Sponsors
Advocacy/Policy/Resources
As the statewide trade association for New Mexico’s life sciences community, NMBio collaborates with various stakeholders in our state to develop a shared set of recommendations and strategies that will support and catalyze life sciences and healthcare ecosystems.
NM Bioscience Stakeholders:
- Air Force Research Lab
- Central New Mexico Community College
- Los Alamos National Laboratory
- New Mexico Bioscience Authority
- New Mexico State University
- New Mexico Tech
- Sandia National Laboratories
- UNM Health Science Center
We work directly with legislative leaders in New Mexico and Washington D.C. to advance NM’s life sciences industry, foster medical innovation and ensure health equity and healthcare affordability.
Our national partners provide us with detailed information on proposed federal legislation and access to their governmental affairs representatives, including the Biotechnology Innovation Organization (BIO), PhRMA, the Council of State Bioscience Associations, (CSBA), and AdvaMed.
Advocacy & Policy Resources
Below are listed many valuable local and national resources to support you and your company’s growth in New Mexico.
In New Mexico
Find My New Mexico Legislator
https://www.nmlegis.gov/members/find_my_legislator
Find My New Mexico US Congressional Member
https://www.congress.gov/members?q=%7B%22member-state%22%3A%22New+Mexico%22%7D
From BIO
BIO Toolkit
Access a range of exclusive resources, educational webinars and up-to-date information on the latest BIO Emerging Companies Section (ECS) events. This comprehensive resource center is designed to empower early-stage companies and help them thrive.
Tax Policy Issues
https://www.bio.org/ecs-resources/digital-resources#tax-policy-issues
BIO is focused on advancing tax policy that recognizes early-stage biotech companies as fundamental to the long-term economic growth of the United States. An overview of BIO’s tax policy priorities are below.
SBIR
https://www.bio.org/ecs-resources/digital-resources#sbir
The SBIR program plays an important role in financing promising early-stage innovation. Here are some resources to help you draft applications and track critical submission deadlines.
BIO Industry Analysis Reports
https://www.bio.org/ecs-resources/digital-resources#industry-analysis
Download past Bio Industry Analysis reports, and sign up to be notified of upcoming reports
FDA Regulation of Laboratory Developed Tests (LDTs) Final Rule
https://www.fda.gov/medical-devices/in-vitro-diagnostics/laboratory-developed-tests
EPA, FDA, and USDA Joint Regulatory Plan for Biotechnology Released April 2024.
FDA
FDA Cannabis Research & Drug Development
